The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review

• Published in: Supportive care in cancer Vol. 24; no. 8; pp. 3669 - 3676
• Main Authors: Atkinson, Thomas M., Ryan, Sean J., Bennett, Antonia V., Stover, Angela M., Saracino, Rebecca M., Rogak, Lauren J., Jewell, Sarah T., Matsoukas, Konstantina, Li, Yuelin, Basch, Ethan
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2016; Springer Nature B.V
• Subjects: Adverse Drug Reaction Reporting Systems - standards; Antineoplastic Agents - adverse effects; Cancer therapies; Drug Monitoring - methods; Drug therapy; Female; Humans; Medicine; Medicine & Public Health; Nursing; Nursing Research; Oncology; Pain Medicine; Patient Reported Outcome Measures; Rehabilitation Medicine; Review Article; Self Report; Side effects; Toxicity; Tumors; Literature review; Self report; Drug monitoring; Drug-related side effects and adverse reactions; Toxicity; Neoplasms
• Online Access: Get full text
• ISSN: 0941-4355; 1433-7339; 1433-7339
• DOI: 10.1007/s00520-016-3297-9

Purpose Symptomatic adverse events (AEs) are monitored by clinicians as part of all US-based clinical trials in cancer via the U.S. National Cancer Institute’s Common Terminology Criteria for Adverse Events (CTCAE) for the purposes of ensuring patient safety. Recently, there has been a charge toward...